Académique Documents
Professionnel Documents
Culture Documents
Maintain BUY with DCF-based IDR6,100 TP, 20% upside, implying 11.7x-10.2x FY19F-20F EV/EBITDA. Jasa Marga plans to
raise IDR700bn via the DINFRA mutual fund issuance. We see this as helping to ease the company’s balance sheet, and finance its
aggressive expansion. It has extensive experience in raising funds, especially alternative financing. We expect it to continue the
advanced external funding programme to finance CPF contracts that are due in 2019, and bond repayments in 2020. Its matured toll
roads – eg Cawang-Tomang-Pluit (Jakarta Inner Ring Road), Soekarno-Hatta International Airport, Jakarta-Tangerang, and
Purbaleunyi – are good choices for asset securitisation.
To raise IDR700bn via mutual fund issuance. We spoke to management, which stated that the company is targeting to obtain
IDR700bn cash via Dana Investasi Infrastruktur (DINFRA) mutual fund issuance on 20 Feb 2019. DINFRA is a mutual fund
investment limited participation (Reksadana Penyertaan Terbatas or “RDPT”) with its underlying asset of the Gempol-Pandaan toll
road section, which is owned by Jasa Marga’s subsidiary PT Jasa Marga Pandaan Tol.
The scheme of Dinfra has not been settled. Our discussion with the management revealed that the scheme is likely to be:
i. PT Jasa Marga Pandaan plans to raise IDR300bn via rights issuance;
ii. Jasa Marga plans to raise IDR400bn via divestment of some stakes in PT Jasa Marga Pandaan;
iii. DINFRA plans to buy a stake in PT Jasa Marga Pandaan via the above rights issuance and divestment, est. price of 2x P/BV;
iv. There is likely a buy-back option in the fifth year, after DINFRA is issued.
The Gempol-Pandaan toll road – which started operating in Mar 2015 – is 13.6km and forms part of the toll road connecting
Surabaya and Malang. Based on the latest financial statement, Jasa Marga owns 92% stake in PT Jasa Marga Pandaan. In 9M18,
revenue for the Gempol-Pandaan toll road was IDR65bn (c.1% of Jasa Marga’s total revenue), while it still booked a net loss of
IDR763m.
Flexibility in funding. Jasa Marga has flexibility and experience in advanced fundraising. On top of taking out conventional bank
loans, the company has, over the last two years, been engaged in the following:
i. Aug 2017 – The Jagorawi Future Revenue-Backed Securities (Kontrak Investasi Kolektif Efek Beragun Aset) issuance that
amounted IDR2trn, with a 5-year term. Notably, Jagorawi’s revenue in 2018-2021F is estimated at IDR4trn, in which half of its
future revenue is securitised in this fund raising. Jasa Marga booked proceeds from this as deferred revenue, which is amortised
at IDR400bn pa;
ii. Oct 2017 – Subsidiary Marga Lingkar Jakarta’s project bond that amounted to IDR1.5trn, comprising five series of bonds (3-12
year terms) with coupons ranging between 7% and 9% pa;
iii. Dec 2017 – Komodo Bond (IDR-denominated bond listed on the London Stock Exchange) that amounted to IDR4trn with a 3-year
term and coupon of 7.5% pa;
iv. Jul 2018 – Mutual Fund Investment Limited Participation (RDPT), which amounted to IDR3trn with a 5-year term and internal rate
of return (IRR) of 10.25% pa. This RDPT includes 20% ownership stake in Jasa Marga subsidiaries Ngawi Kertosono Jaya,
Jasamarga Semarang Stem, and Jasamarga Solo Ngawi;
v. Aug 2018 – Divestment of 10% stake in subsidiary Jakarta Lingkar Barat Satu.
Indonesia RHB and/or its subsidiaries are not liquidity providers or market makers for the
This report is issued and distributed in Indonesia by PT RHB Sekuritas Indonesia. subject company (ies) covered in this report except for:
This research does not constitute an offering document and it should not be (a) -
construed as an offer of securities in Indonesia. Any securities offered or sold,
directly or indirectly, in Indonesia or to any Indonesian citizen or corporation RHB and/or its subsidiaries have not participated as a syndicate member in share
(wherever located) or to any Indonesian resident in a manner which constitutes a offerings and/or bond issues in securities covered in this report in the last 12 months
public offering under Indonesian laws and regulations must comply with the except for:
prevailing Indonesian laws and regulations. (a) -
Singapore RHB has not provided investment banking services to the company/companies
This report is issued and distributed in Singapore by RHB Research Institute covered in this report in the last 12 months except for:
Singapore Pte Ltd and it may only be distributed in Singapore to accredited (a) -
investors, expert investors and institutional investors as defined in the Financial
Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended Thailand
from time to time. By virtue of distribution to these categories of investors, RHB RHB Securities (Thailand) PCL and/or its directors, officers, associates, connected
Research Institute Singapore Pte Ltd and its representatives are not required to parties and/or employees, may have, or have had, interests and/or commitments in
comply with Section 36 of the Financial Advisers Act (Chapter 110) (Section 36 the securities in subject company(ies) mentioned in this report or any securities
relates to disclosure of RHB Research Institute Singapore Pte Ltd ’s interest and/or related thereto. Further, RHB Securities (Thailand) PCL may have, or have had,
its representative's interest in securities). Recipients of this report in Singapore may business relationships with the subject company(ies) mentioned in this report. As a
contact RHB Research Institute Singapore Pte Ltd in respect of any matter arising result, investors should exercise their own judgment carefully before making any
from or in connection with the report. investment decisions.
RHBHK had an investment banking services client relationships during the past 12
months with: -.
RHBHK has received compensation for investment banking services, during the past
12 months from: -.
RHBHK salespeople, traders, and other non-research professionals may provide oral
or written market commentary or trading strategies to RHB clients that reflect
opinions that are contrary to the opinions expressed in this research report.